Rebound-associated vertebral fractures after discontinuation of denosumab-from clinic and biomechanics. [electronic resource]
Producer: 20170110Description: 1917-21 p. digitalISSN:- 1433-2965
- Aromatase Inhibitors -- adverse effects
- Bone Density Conservation Agents -- administration & dosage
- Bone Diseases, Metabolic -- chemically induced
- Breast Neoplasms -- drug therapy
- Denosumab -- administration & dosage
- Drug Administration Schedule
- Female
- Humans
- Middle Aged
- Osteoporotic Fractures -- etiology
- Spinal Fractures -- etiology
- Withholding Treatment
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.